Public signalCompany raiseAuto-indexed · Unverified
Panbela Therapeutics, Inc. raised $2.0M
Panbela Therapeutics, Inc.· Waconia, US· Pharmaceuticals· Filed Jan 5, 2024
Panbela Therapeutics, Inc. reported raising capital. Based in Waconia, MINNESOTA, US. First sale reported 2023-12-21. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$2.0M
Confidence90%
Raised
$2.0M
Investors
2
Jurisdiction
DELAWARE
On the record
- Location
- Waconia, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $2.0M
- Filing date
- Jan 5, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 2
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- Indefinite
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Arthur J. Fratamico
Director
Waconia, US
Daniel Donovan
Director
Waconia, US
Jeffrey E. Jacob
Director
Waconia, US
Jeffrey S. Mathiesen
Director
Waconia, US
Jennifer K. Simpson
Executive Officer
Waconia, US
Michael T. Cullen
Director
Waconia, US
Robert Schemel
Director
Waconia, US
Susan Horvath
Executive Officer
Waconia, US
Sources & provenance
“Operating company sold 2,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 5, 2024. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticals$1M – $10MCompany Raise
Are you associated with Panbela Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record